Patents by Inventor Mark Andrew Miller

Mark Andrew Miller has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • surface protein SA1789 and protective vaccine based thereon
    Patent number: 8747858
    Abstract: The novel protein SA1789 from Staphylococcus aureus is provided as well as nucleic acid and nucleic acid sequence homologues encoding this protein. Also provided is a composition, particularly a S. aureus vaccine, comprising SA1789 protein or a fragment or derivative thereof capable of generating an immune response that leads to the killing and clearance of S. aureus.
    Type: Grant
    Filed: July 8, 2011
    Date of Patent: June 10, 2014
    Assignee: Merck Sharp & Dohme Corp.
    Inventors: Tessie B. McNeely, Hongxia Fan, Mark Andrew Miller
  • STAPHYLOCOCCUS AUREUS SURFACE PROTEIN SA1789 AND PROTECTIVE VACCINE BASED THEREON
    Publication number: 20130122034
    Abstract: The novel protein SA1789 from Staphylococcus aureus is provided as well as nucleic acid and nucleic acid sequence homologues encoding this protein. Also provided is a composition, particularly a S. aureus vaccine, comprising SA1789 protein or a fragment or derivative thereof capable of generating an immune response that leads to the killing and clearance of S. aureus.
    Type: Application
    Filed: July 8, 2011
    Publication date: May 16, 2013
    Inventors: Tessie B. McNeely, Hongxia Fan, Mark Andrew Miller